CannLabs, Inc. (CANL)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
-90.91%
Market Cap 94.22K
Revenue (ttm) 1.72M
Net Income (ttm) -1.69M
Shares Out 942.16M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,036
Average Volume 9,474
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0401
Beta 273.84
RSI 99.48
Earnings Date n/a

About CannLabs

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado. [Read more]

Sector Healthcare
Founded 2010
Employees 37
Stock Exchange OTCMKTS
Ticker Symbol CANL
Full Company Profile

Financial Performance

Financial Statements

News

CannLabs, Inc's 2021 Annual General Meeting Announcement

HOUSTON, Dec. 7, 2021 /PRNewswire/ -- Publicly Traded company CannLabs, Inc. (OTC Pink: CANL) announced today that it conducted its Annual General Shareholders Meeting on the 19th of November 2021 at ...

3 years ago - PRNewsWire